This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Enanta Pharmaceuticals Inc (ENTA)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 31.96
52 Week High 52.58
52 Week Low 16.75
Avg. Daily Vol. (Mil) 0.36
Beta (3 year) 0.26
Share Related Items
Mkt Cap (Mil) 598.10
Shares Out (Mil) 18.71
Float (Mil) 15.74
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 22.90
Current Ratio 23.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 7.80
Price/Sales 3.72
Price/Book 2.62
Price/Cash Flow 8.40
Per Share Data
Earnings 4.09
Sales 8.60
Book Value 12.20
Cash Flow 3.78
Business Summary
Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Company uses its chemistry-driven approach & drug discovery capabilities to develop its products.
General Information
500 Arsenal Street
Watertown, MA 02472
Industry : Drugs
Sector: Health Care
Employees: 52
CEO: Dr. Jay R. Luly
Short Interest
Current Month (Mil) 4.09
Previous Month (Mil) 3.98
Short Interest Ratio (Days) 7.30
Management Effectiveness
Return on Equity 29.80
Return on Assets 28.70
Return on Investments 29.80
Gross Margin n.a.
EBIT Margin 76.10
Profit Margin 49.10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ENTA Enanta Pharmaceuticals Inc

Chart of ENTA

Analysts Ratings for ENTA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 3 2 3
Moderate Buy 0 0 0 0
Hold 1 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0

ENTA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs